Barclays PLC Raises Holdings in Select Medical Holdings Co. (NYSE:SEM)

Barclays PLC raised its stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 29.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 249,209 shares of the health services provider's stock after buying an additional 56,852 shares during the period. Barclays PLC owned about 0.19% of Select Medical worth $4,698,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the company. Smartleaf Asset Management LLC lifted its position in shares of Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after buying an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of Select Medical in the third quarter worth about $81,000. Covestor Ltd increased its position in Select Medical by 33.5% in the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after purchasing an additional 1,244 shares during the last quarter. Virtu Financial LLC purchased a new stake in shares of Select Medical during the 3rd quarter valued at about $210,000. Finally, Tidal Investments LLC purchased a new position in shares of Select Medical in the 3rd quarter worth approximately $286,000. Institutional investors own 89.48% of the company's stock.

Insider Buying and Selling at Select Medical

In other Select Medical news, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the sale, the chief executive officer now owns 714,516 shares of the company's stock, valued at $12,861,288. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have recently commented on SEM. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Mizuho began coverage on Select Medical in a report on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price target for the company. Royal Bank of Canada cut their price target on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research note on Monday, February 24th. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective on the stock in a report on Monday, February 24th. Finally, UBS Group cut their price target on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a report on Friday, January 3rd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, Select Medical has an average rating of "Moderate Buy" and a consensus price target of $26.80.

Select Medical Stock Performance

Shares of SEM traded up $0.04 during mid-day trading on Thursday, reaching $18.28. The company had a trading volume of 718,799 shares, compared to its average volume of 834,841. The stock has a market capitalization of $2.36 billion, a P/E ratio of 11.08, a PEG ratio of 0.64 and a beta of 1.38. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a 50 day moving average of $17.02 and a two-hundred day moving average of $22.07. Select Medical Holdings Co. has a 52-week low of $14.99 and a 52-week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.31 billion during the quarter, compared to analysts' expectations of $1.50 billion. On average, analysts expect that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.37%. The ex-dividend date was Monday, March 3rd. Select Medical's payout ratio is currently 15.15%.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.